Sign In

Login

Password

Forgot Password ? Sign Up

Targeted drug delivery (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Targeted drug delivery" in French language version.

refsWebsite
Global rank French rank
11doi.org
2nd place
3rd place
10nih.gov
4th place
12th place
1accessscience.com
low place
low place
1sciencedirect.com
149th place
80th place
1umn.edu
1,266th place
2,345th place

accessscience.com

doi.org

dx.doi.org

  • R Muller et C Keck, « Challenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticles », Journal of Biotechnology, vol. 113, nos 1–3,‎ , p. 151–170 (PMID 15380654, DOI 10.1016/j.jbiotec.2004.06.007)
  • N Bertrand et JC. Leroux, « The journey of a drug carrier in the body: an anatomo-physiological perspective », Journal of Controlled Release, vol. 161, no 2,‎ , p. 152–63 (PMID 22001607, DOI 10.1016/j.jconrel.2011.09.098, lire en ligne)
  • Robert C Scott, Deborah Crabbe, Barbara Krynska, Ramin Ansari et Mohammad F Kiani, « Aiming for the heart: targeted delivery of drugs to diseased cardiac tissue », Expert Opinion on Drug Delivery, vol. 5, no 4,‎ , p. 459–70 (PMID 18426386, DOI 10.1517/17425247.5.4.459)
  • M Cobleigh, VK Langmuir, GW Sledge, KD Miller, L Haney, WF Novotny, JD Reimann et A Vassel, « A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer », Seminars in Oncology, vol. 30, no 5 Suppl 16,‎ , p. 117–24 (PMID 14613032, DOI 10.1053/j.seminoncol.2003.08.013)
  • A. Seidman, C Hudis, MK Pierri, S Shak, V Paton, M Ashby, M Murphy, SJ Stewart et D Keefe, « Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience », Journal of Clinical Oncology, vol. 20, no 5,‎ , p. 1215–21 (PMID 11870163, DOI 10.1200/JCO.20.5.1215)
  • Adam Brufsky, « Trastuzumab-Based Therapy for Patients With HER2-Positive Breast Cancer », American Journal of Clinical Oncology, vol. 33, no 2,‎ , p. 186–95 (PMID 19675448, DOI 10.1097/COC.0b013e318191bfb0)
  • R. Pili, M. A. Rosenthal, P. N. Mainwaring, G. Van Hazel, S. Srinivas, R. Dreicer, S. Goel, J. Leach, S. Wong et P. Clingan, « Phase II Study on the Addition of ASA404 (Vadimezan; 5,6-Dimethylxanthenone-4-Acetic Acid) to Docetaxel in CRMPC », Clinical Cancer Research, vol. 16, no 10,‎ , p. 2906–14 (PMID 20460477, DOI 10.1158/1078-0432.CCR-09-3026)
  • J. Homsi, G. R. Simon, C. R. Garrett, G. Springett, R. De Conti, A. A. Chiappori, P. N. Munster, M. K. Burton, S. Stromatt, C. Allievi, P. Angiuli, A. Eisenfeld, D. M. Sullivan et A. I. Daud, « Phase I Trial of Poly-L-Glutamate Camptothecin (CT-2106) Administered Weekly in Patients with Advanced Solid Malignancies », Clinical Cancer Research, vol. 13, no 19,‎ , p. 5855–61 (PMID 17908979, DOI 10.1158/1078-0432.CCR-06-2821)
  • V. G. Vogel, JP Costantino, DL Wickerham, WM Cronin, RS Cecchini, JN Atkins, TB Bevers, L Fehrenbacher, ER Pajon Jr, 3rd Wade Jl, A Robidoux, R. G. Margolese, J James, S. M. Lippman, C. D. Runowicz, P. A. Ganz, S. E. Reis, W McCaskill-Stevens, L. G. Ford, V. C. Jordan et N Wolmark, National Surgical Adjuvant Breast Bowel Project (NSABP), « Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial », JAMA, vol. 295, no 23,‎ , p. 2727–41 (PMID 16754727, DOI 10.1001/jama.295.23.joc60074)
  • M. Kahan, B. Gil, R. Adar et E. Shapiro, « Towards Molecular Computers that Operate in a Biological Environment », Physica D: Nonlinear Phenomena, vol. 237,‎ , p. 1165-1172 (DOI 10.1016/j.physd.2008.01.027)
  • Ebbe S. Andersen, Mingdong Dong, Morten M. Nielsen, Kasper Jahn, Ramesh Subramani, Wael Mamdouh, Monika M. Golas, Bjoern Sander, Holger Stark, Cristiano L. P. Oliveira, Jan Skov Pedersen, Victoria Birkedal, Flemming Besenbacher, Kurt V. Gothelf et Jørgen Kjems, « Self-assembly of a nanoscale DNA box with a controllable lid », Nature, vol. 459, no 7243,‎ , p. 73–6 (PMID 19424153, DOI 10.1038/nature07971)

nih.gov

ncbi.nlm.nih.gov

  • R Muller et C Keck, « Challenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticles », Journal of Biotechnology, vol. 113, nos 1–3,‎ , p. 151–170 (PMID 15380654, DOI 10.1016/j.jbiotec.2004.06.007)
  • N Bertrand et JC. Leroux, « The journey of a drug carrier in the body: an anatomo-physiological perspective », Journal of Controlled Release, vol. 161, no 2,‎ , p. 152–63 (PMID 22001607, DOI 10.1016/j.jconrel.2011.09.098, lire en ligne)
  • Robert C Scott, Deborah Crabbe, Barbara Krynska, Ramin Ansari et Mohammad F Kiani, « Aiming for the heart: targeted delivery of drugs to diseased cardiac tissue », Expert Opinion on Drug Delivery, vol. 5, no 4,‎ , p. 459–70 (PMID 18426386, DOI 10.1517/17425247.5.4.459)
  • M Cobleigh, VK Langmuir, GW Sledge, KD Miller, L Haney, WF Novotny, JD Reimann et A Vassel, « A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer », Seminars in Oncology, vol. 30, no 5 Suppl 16,‎ , p. 117–24 (PMID 14613032, DOI 10.1053/j.seminoncol.2003.08.013)
  • A. Seidman, C Hudis, MK Pierri, S Shak, V Paton, M Ashby, M Murphy, SJ Stewart et D Keefe, « Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience », Journal of Clinical Oncology, vol. 20, no 5,‎ , p. 1215–21 (PMID 11870163, DOI 10.1200/JCO.20.5.1215)
  • Adam Brufsky, « Trastuzumab-Based Therapy for Patients With HER2-Positive Breast Cancer », American Journal of Clinical Oncology, vol. 33, no 2,‎ , p. 186–95 (PMID 19675448, DOI 10.1097/COC.0b013e318191bfb0)
  • R. Pili, M. A. Rosenthal, P. N. Mainwaring, G. Van Hazel, S. Srinivas, R. Dreicer, S. Goel, J. Leach, S. Wong et P. Clingan, « Phase II Study on the Addition of ASA404 (Vadimezan; 5,6-Dimethylxanthenone-4-Acetic Acid) to Docetaxel in CRMPC », Clinical Cancer Research, vol. 16, no 10,‎ , p. 2906–14 (PMID 20460477, DOI 10.1158/1078-0432.CCR-09-3026)
  • J. Homsi, G. R. Simon, C. R. Garrett, G. Springett, R. De Conti, A. A. Chiappori, P. N. Munster, M. K. Burton, S. Stromatt, C. Allievi, P. Angiuli, A. Eisenfeld, D. M. Sullivan et A. I. Daud, « Phase I Trial of Poly-L-Glutamate Camptothecin (CT-2106) Administered Weekly in Patients with Advanced Solid Malignancies », Clinical Cancer Research, vol. 13, no 19,‎ , p. 5855–61 (PMID 17908979, DOI 10.1158/1078-0432.CCR-06-2821)
  • V. G. Vogel, JP Costantino, DL Wickerham, WM Cronin, RS Cecchini, JN Atkins, TB Bevers, L Fehrenbacher, ER Pajon Jr, 3rd Wade Jl, A Robidoux, R. G. Margolese, J James, S. M. Lippman, C. D. Runowicz, P. A. Ganz, S. E. Reis, W McCaskill-Stevens, L. G. Ford, V. C. Jordan et N Wolmark, National Surgical Adjuvant Breast Bowel Project (NSABP), « Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial », JAMA, vol. 295, no 23,‎ , p. 2727–41 (PMID 16754727, DOI 10.1001/jama.295.23.joc60074)
  • Ebbe S. Andersen, Mingdong Dong, Morten M. Nielsen, Kasper Jahn, Ramesh Subramani, Wael Mamdouh, Monika M. Golas, Bjoern Sander, Holger Stark, Cristiano L. P. Oliveira, Jan Skov Pedersen, Victoria Birkedal, Flemming Besenbacher, Kurt V. Gothelf et Jørgen Kjems, « Self-assembly of a nanoscale DNA box with a controllable lid », Nature, vol. 459, no 7243,‎ , p. 73–6 (PMID 19424153, DOI 10.1038/nature07971)

sciencedirect.com

umn.edu

license.umn.edu